EluNIR

Ridaforolimus Eluting Coronary Stent System

Excellent clinical outcomes
Redefining deliverability with a new spring tip
Low footprint cobalt-chromium design
Optimal conformability and vessel support
Elastomeric coating and outstanding surface integrity
Eluting Ridaforolimus, a high therapeutic index limus drug

* Kandzari, David E. et al. Randomized comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stent in Patients with Coronary Artery Disease (2017) 136: 1304-1314

** Presented at CRT2018

EluNIR - elastomeric Drug Eluting Stent

EluNIR is CE Marked and FDA approved (38mm and 44mm lengths are not approved in the United States). For information on other countries please contact Medinol

Request Information